Literature DB >> 27825049

Crystal structure of a polypeptide's C-terminus in complex with the regulatory domain of ER aminopeptidase 1.

Lufei Sui1, Amit Gandhi2, Hwai-Chen Guo3.   

Abstract

Endoplasmic reticulum aminopeptidase 1 (ERAP1) is involved in the final processing of peptide precursors to generate the N-termini of MHC class I-restricted epitopes. ERAP1 thus influences immunodominance and cytotoxic immune responses by controlling the peptide repertoire available for cell surface presentation by MHC molecules. To enable this critical role in antigen processing, ERAP1 trims peptides by a unique molecular ruler mechanism that turns on/off hydrolysis activity in a peptide-length and -sequence dependent manner. Thus unlike other aminopeptidases, ERAP1 could recognize both the N- and C-termini of peptides in order to read the substrate's length. To exemplify and validate this molecular ruler mechanism, we have carried out crystallographic studies on molecular recognition of antigenic peptide's C-terminus by ERAP1. In this report, we have determined a 2.8Å-resolution crystal structure of an intermolecular complex between the ERAP1 regulatory domain and a natural epitope's C-terminus displayed in a fusion protein. It reveals the structural details of peptide's C-termini recognition by ERAP1. ERAP1 uses specificity pockets on the regulatory domain to bind the peptide's carboxyl end and side chain of the C-terminal anchoring residue. At the same time, flexibility in length and sequence at the middle of peptides is accommodated by a kink with minimal interactions with ERAP1. Copyright Â
© 2016 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Antigen-ERAP1 interactions; C-terminus recognition; Complex structure; ERAP1 regulatory domain; Endoplasmic reticulum aminopeptidase 1; Molecular ruler mechanism

Mesh:

Substances:

Year:  2016        PMID: 27825049      PMCID: PMC5148704          DOI: 10.1016/j.molimm.2016.10.012

Source DB:  PubMed          Journal:  Mol Immunol        ISSN: 0161-5890            Impact factor:   4.407


  29 in total

Review 1.  SYFPEITHI: database for MHC ligands and peptide motifs.

Authors:  H Rammensee; J Bachmann; N P Emmerich; O A Bachor; S Stevanović
Journal:  Immunogenetics       Date:  1999-11       Impact factor: 2.846

2.  ERAAP modulation: A possible novel strategy for cancer immunotherapy?

Authors:  Doriana Fruci; Franco Locatelli; Loredana Cifaldi
Journal:  Oncoimmunology       Date:  2012-01-01       Impact factor: 8.110

Review 3.  Endoplasmic reticulum aminopeptidase 1 function and its pathogenic role in regulating innate and adaptive immunity in cancer and major histocompatibility complex class I-associated autoimmune diseases.

Authors:  D Fruci; P Romania; V D'Alicandro; F Locatelli
Journal:  Tissue Antigens       Date:  2014-08

4.  Comparison of the P2 specificity pocket in three human histocompatibility antigens: HLA-A*6801, HLA-A*0201, and HLA-B*2705.

Authors:  H C Guo; D R Madden; M L Silver; T S Jardetzky; J C Gorga; J L Strominger; D C Wiley
Journal:  Proc Natl Acad Sci U S A       Date:  1993-09-01       Impact factor: 11.205

5.  Concerted peptide trimming by human ERAP1 and ERAP2 aminopeptidase complexes in the endoplasmic reticulum.

Authors:  Loredana Saveanu; Oliver Carroll; Vivian Lindo; Margarita Del Val; Daniel Lopez; Yves Lepelletier; Fiona Greer; Lutz Schomburg; Doriana Fruci; Gabriele Niedermann; Peter M van Endert
Journal:  Nat Immunol       Date:  2005-05-22       Impact factor: 25.606

6.  Secretion of endoplasmic reticulum aminopeptidase 1 is involved in the activation of macrophages induced by lipopolysaccharide and interferon-gamma.

Authors:  Yoshikuni Goto; Kenji Ogawa; Akira Hattori; Masafumi Tsujimoto
Journal:  J Biol Chem       Date:  2011-04-29       Impact factor: 5.157

7.  Structural basis for antigenic peptide precursor processing by the endoplasmic reticulum aminopeptidase ERAP1.

Authors:  Tina T Nguyen; Shih-Chung Chang; Irini Evnouchidou; Ian A York; Christos Zikos; Kenneth L Rock; Alfred L Goldberg; Efstratios Stratikos; Lawrence J Stern
Journal:  Nat Struct Mol Biol       Date:  2011-04-10       Impact factor: 15.369

8.  Major histocompatibility complex associations of ankylosing spondylitis are complex and involve further epistasis with ERAP1.

Authors:  Adrian Cortes; Sara L Pulit; Paul J Leo; Jenny J Pointon; Philip C Robinson; Michael H Weisman; Michael Ward; Lianne S Gensler; Xiaodong Zhou; Henri-Jean Garchon; Gilles Chiocchia; Johannes Nossent; Benedicte A Lie; Øystein Førre; Jaakko Tuomilehto; Kari Laiho; Linda A Bradbury; Dirk Elewaut; Ruben Burgos-Vargas; Simon Stebbings; Louise Appleton; Claire Farrah; Jonathan Lau; Nigil Haroon; Juan Mulero; Francisco J Blanco; Miguel A Gonzalez-Gay; C Lopez-Larrea; Paul Bowness; Karl Gaffney; Hill Gaston; Dafna D Gladman; Proton Rahman; Walter P Maksymowych; J Bart A Crusius; Irene E van der Horst-Bruinsma; Raphael Valle-Oñate; Consuelo Romero-Sánchez; Inger Myrnes Hansen; Fernando M Pimentel-Santos; Robert D Inman; Javier Martin; Maxime Breban; Bryan Paul Wordsworth; John D Reveille; David M Evans; Paul I W de Bakker; Matthew A Brown
Journal:  Nat Commun       Date:  2015-05-21       Impact factor: 14.919

9.  The internal sequence of the peptide-substrate determines its N-terminus trimming by ERAP1.

Authors:  Irini Evnouchidou; Frank Momburg; Athanasios Papakyriakou; Angeliki Chroni; Leondios Leondiadis; Shih-Chung Chang; Alfred L Goldberg; Efstratios Stratikos
Journal:  PLoS One       Date:  2008-11-06       Impact factor: 3.240

10.  ERAP1-ERAP2 dimers trim MHC I-bound precursor peptides; implications for understanding peptide editing.

Authors:  Hanna Chen; Lenong Li; Mirjana Weimershaus; Irini Evnouchidou; Peter van Endert; Marlene Bouvier
Journal:  Sci Rep       Date:  2016-08-12       Impact factor: 4.379

View more
  7 in total

1.  Mechanism for antigenic peptide selection by endoplasmic reticulum aminopeptidase 1.

Authors:  Petros Giastas; Anastasia Mpakali; Athanasios Papakyriakou; Aggelos Lelis; Paraskevi Kokkala; Margarete Neu; Paul Rowland; John Liddle; Dimitris Georgiadis; Efstratios Stratikos
Journal:  Proc Natl Acad Sci U S A       Date:  2019-12-16       Impact factor: 11.205

2.  Discovery of Selective Inhibitors of Endoplasmic Reticulum Aminopeptidase 1.

Authors:  Zachary Maben; Richa Arya; Digamber Rane; W Frank An; Shailesh Metkar; Marc Hickey; Samantha Bender; Akbar Ali; Tina T Nguyen; Irini Evnouchidou; Roger Schilling; Efstratios Stratikos; Jennifer Golden; Lawrence J Stern
Journal:  J Med Chem       Date:  2019-12-30       Impact factor: 7.446

Review 3.  Molecular pathways for antigenic peptide generation by ER aminopeptidase 1.

Authors:  Anastasia Mpakali; Zachary Maben; Lawrence J Stern; Efstratios Stratikos
Journal:  Mol Immunol       Date:  2018-04-17       Impact factor: 4.407

4.  A systematic re-examination of processing of MHCI-bound antigenic peptide precursors by endoplasmic reticulum aminopeptidase 1.

Authors:  George Mavridis; Richa Arya; Alexander Domnick; Jerome Zoidakis; Manousos Makridakis; Antonia Vlahou; Anastasia Mpakali; Angelos Lelis; Dimitris Georgiadis; Robert Tampé; Athanasios Papakyriakou; Lawrence J Stern; Efstratios Stratikos
Journal:  J Biol Chem       Date:  2020-03-17       Impact factor: 5.157

Review 5.  The Role of Conformational Dynamics in Antigen Trimming by Intracellular Aminopeptidases.

Authors:  Athanasios Papakyriakou; Efstratios Stratikos
Journal:  Front Immunol       Date:  2017-08-07       Impact factor: 7.561

6.  ERAP1 Controls the Interaction of the Inhibitory Receptor KIR3DL1 With HLA-B51:01 by Affecting Natural Killer Cell Function.

Authors:  Silvia D'Amico; Valerio D'Alicandro; Mirco Compagnone; Patrizia Tempora; Giusy Guida; Paolo Romania; Valeria Lucarini; Ombretta Melaiu; Michela Falco; Mattia Algeri; Daniela Pende; Loredana Cifaldi; Doriana Fruci
Journal:  Front Immunol       Date:  2021-11-30       Impact factor: 7.561

7.  ERAP1 binds peptide C-termini of different sequences and/or lengths by a common recognition mechanism.

Authors:  Lufei Sui; Hwai-Chen Guo
Journal:  Immunobiology       Date:  2021-07-04       Impact factor: 3.152

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.